The Hidden Truth – CDC Recommended Childhood Vaccines

      1. HepB (Hepatitis B)
        This vaccine is contraindicated for name because it contains Lactate dehydrogenase-elevating virus
        (LDV) which is a mouse arterivirus pathogenic infection of neurons in the central nervous system.
        *The vaccine also contains Envelope E protein – 75 amino acids long, the envelope (E) protein is
        the smallest of the four structural proteins that make up the SARS-CoV-2 viral particle and is
        essential for the virus to infect cells. This presents a clear medical danger to name because these
        toxins would be exacerbated by introduction of this substance to his/her body.

    Supporting studies/evidence:
    Safety Datasheet: ENGERIX-B PRESERVATIVE FREE = * HEPATITIS B SURFACE ANTIGEN
    https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.pdf

    Vaccine – Hepatitis B (Recombinant DNA) Vaccine (Absorbed)
    Composition/information on ingredients: Disodium Hydrogen Phosphate
    https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.pdf

    *Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19
    patients
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282743/

        1. RV* Rotavirus
          This vaccine is contraindicated for name because it increased risk of intussusception in vaccinated
          infants. Intussusception is a medical emergency that needs care right away. It is the most common
          abdominal emergency in children under 2 years old. An associated protein coding gene (ingredient)
          is CRAT (Carnitine O-acetyltransferase).
          Diseases Associations are: Acute diabetes complication and Ischemia; and diseases associated with
          CRAT include Neurodegeneration With Brain Iron Accumulation 8 and Neurodegeneration With Brain Iron
          Accumulation (NBIA). NBIA are neurologic disorders, causing include; muscular spasms, twisting, and
          repetitive movements, spasticity, parkinsonism (slurred or slow speech, stiffness of the muscles,
          slow movement, and visible tremors), inability to coordinate movements (ataxia), neuropsychiatric
          abnormalities (confusion, disorientation, seizures, stupor, dementia), and eye problems, such as
          optic atrophy or retinal degeneration. Cerebellar atrophy is common in many cases. This presents a
          clear medical danger to name because these toxins would be exacerbated by introduction of this
          substance to his/her body.
          https://www.sciencedirect.com/science/article/abs/pii/S0264410X21012822

      Supporting studies/evidence:
      What Is Intussusception?
      https://kidshealth.org/en/parents/intussusception.html
      https://www.mayoclinic.org/diseases-conditions/intussusception/symptoms-causes/syc-20351452

      Neurodegeneration with Brain Iron Accumulation
      https://rarediseases.info.nih.gov/diseases/11899/neurodegeneration-with-brain-iron-accumulation

          1. DTaP Diphtheria, Pertussis, & Tetanus – BOOSTRIX (FDA recommended)
            This vaccine is contraindicated for name because it contains Recombinant Exotoxin A of Pseudomonas
            aeruginosa. Exotoxin A is a potent cytotoxin and is known to be lethal. Exotoxin A causes disease
            by inhibition of protein synthesis, direct cytopathic effects, and interference with cellular
            immune functions of the host/ child. BOOSTRIX also is linked to the protein Mucin-1 (human), which
            contributes to cellular processes and dysregulation, and can facilitate in distinct human diseases.
            This presents a clear medical danger to name because these toxins would be exacerbated by
            introduction of this substance to his/her body.

        Supporting studies/evidence:
        The role of exotoxin A in pseudomonas disease and immunity
        https://pubmed.ncbi.nlm.nih.gov/6419320/

        Mucin-1 (human)
        Mucin 1 – Protein-Disease Associations – https://pubchem.ncbi.nlm.nih.gov/protein/P15941 –
        section=Diseases-and- Phenotypes

        Diphtheria toxoids
        https://www.cdc.gov/vaccines/pubs/pinkbook/dip.html

            1. Hib* Haemophilus influenzae type b
              PedvaxHIB (PRP-OMP, Merck) –
              Synonym: Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol
              Modified For Conjugation
              This vaccine is contraindicated for name. because it contains the chemical Atropine, which is
              registered as a hazardous substances, and an environmental contaminant. Atropine in toxic amounts
              leads to drowsiness, stupor, convulsions, & coma, and death. Symptoms of atropine toxicity include:
              dryness of the mouth; flushed, hot, & dry skin; dilated & nonreactive pupils; tachycardia;
              hallucinations; & restlessness. Seizures without prior evidence of hallucinations or delirium have
              followed the use of atropine in children. This presents a clear medical danger to name because
              these toxins would be exacerbated by introduction of this substance to his/her body.
              Supporting studies/evidence:
              haemophilus b conjugate vaccine (meningococcal protein conjugate)
              https://www.drugs.com/pro/pedvaxhib.html
              Atropine –
              Atropine has been used as a premedication in obstetric anesthesia, as a test of fetoplacental
              insufficiency, & in the diagnosis of fetal asphyxia (atropine given to the mother produces changes
              in the fetal heart rate: first bradycardia, then tachycardia). There is evidence of rapid placental
              transfer of atropine. https://pubchem.ncbi.nlm.nih.gov/source/hsdb/2199

          Atropine Data sheet –
          https://pubchem.ncbi.nlm.nih.gov/compound/Atropine#section=GHS-Classification

          Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol Modified For
          Conjugation
          https://gsrs.ncats.nih.gov/ginas/app/beta/substances/MC95ZF3C5A
          https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46KSF1PRP7

              1. PCV13, PCV15 (Pneumococcal disease)
                Name: Vaxneuvance (Merck) Pneumococcal 15-valent – suspension for injection in pre-filled syringe
                This vaccine is contraindicated for name because it contains Amlodipine (Norvasc). Amlodipine is an
                antihypertensive agent, and a vasodilator agent; which can cause a decrease in blood pressure. *GHS
                Hazard Statements – Toxic if swallowed. Danger Acute toxicity, oral corrosive, and an environmental
                contaminant. Causes serious eye damage.
                Causes damage to organs through prolonged or repeated exposure. *Warning: Specific target organ
                toxicity, repeated exposure. Very toxic to aquatic life with long lasting effects. This presents a
                clear medical danger to name because this toxin would be exacerbated by introduction of this
                substance to his/her body.
                Supporting studies/evidence
                Amlodipine
                https://pubchem.ncbi.nlm.nih.gov/compound/amlodipine
                Norvasc
                https://www.mayoclinic.org/drugs-supplements/amlodipine-oral-route/description/drg-20061784

            Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient] (Code N0000179488)
            https://nciterms.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NDFRT&version=February
            2018&code=N0
            000179488&ns=NDFRT&type=all&key=null&b=1&n=0&vse=null

                1. IPV – Poliovirus Vaccine, inactivated
                  This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can
                  produce neurotoxicity, ototoxicity and/or nephrotoxicity. Neomycin is associated with delayed-onset
                  irreversible deafness, renal failure and death due to neuromuscular blockade (regardless of the
                  status of renal function). GHS Hazard Statements: Harmful if swallowed: Acute toxicity, oral. May
                  cause a serious allergic skin reaction May cause allergy or asthma symptoms or breathing
                  difficulties if inhaled. Inactivated poliovirus vaccine administration has been associated with
                  Guillain-Barre Syndrome. *Neomycin is used in veterinary medicine as a bactericidal drug. This
                  presents a clear medical danger to name because this toxin would be exacerbated by introduction of
                  this substance to his/her body.

              Supporting studies/evidence:
              Neomycin
              https://pubchem.ncbi.nlm.nih.gov/compound/neomycin

              *Neomycin – Necrosis – The death of cells in an organ or tissue due to disease, injury or failure
              of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic – The random
              catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological
              death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin –
              section=Associated-Disorders-and-Diseases

                  1. COVID-19** Coronavirus disease 2019
                    This recombinant nanoparticle vaccine is contraindicated for name because it contains the
                    full-length spike glycoprotein of the prototype strain plus *Matrix-M adjuvant. Matrix-M adjuvant
                    induces early activation of innate immune cells at the injection site and in the draining lymph
                    nodes. It is unsafe when used in larger amounts as medicine. The Matrix-M adjuvant consists of two
                    distinct fractions of saponins purified from the Quillaja saponaria Molina tree, combined with
                    cholesterol and phospholipids to form 40-nm open cage-like nanoparticles. Quillaia contains high
                    amounts of tannins which can cause stomach problems, as well as kidney and liver damage. Quillaia
                    also contains chemicals called oxalates, which can cause kidney stones. Additional serious adverse
                    events with this vaccine: cases of myocarditis, cases of pericarditis, cases of Multisystem
                    Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in
                    hospitalization or death following administration of the Novavax COVID-19 Vaccine, Adjuvanted.
                    *NVX-CoV2373 in the United States has received Emergency Use Authorization, it is not FDA approved
                    This presents a clear medical danger to name because this toxins, and the additional adverse health
                    concerns would be exacerbated by introduction of this substance to his/her body.

                FDA Briefing Document Novavax COVID-19 Vaccine
                https://www.fda.gov/media/158912/download

                Supporting studies/evidence
                Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in
                Absence of Antigen
                https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041451

                Additional information on Novavax
                *The Novavax COVID-19 Vaccine, Adjuvanted is a suspension for intramuscular injection.
                Product label Generic name: nvx-cov2373 Dosage form: injection, suspension Drug class: Viral
                vaccines Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report all
                vaccine administration errors, all serious adverse events, cases of myocarditis, cases of
                pericarditis, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of
                COVID-19 that result in hospitalization or death following administration of the Novavax COVID-19
                Vaccine, Adjuvanted.
                See “MANDATORY REQUIREMENTS FOR THE NOVAVAX COVID-19 VACCINE, ADJUVANTED
                ADMINISTRATION UNDER EMERGENCY USE AUTHORIZATION” for reporting requirements.
                https://www.drugs.com/pro/covid-19-vaccine-novavax.html

                    1. Flu† Influenza
                      This vaccine is contraindicated for name because it can trigger severe allergic reactions such as
                      asthma and precaution is advised with use of quadrivalent live attenuated influenza vaccine (LAIV4)
                      in persons aged ≥5 years because of concerns for wheezing events. Reactions include, in addition to
                      asthma (e.g., anaphylaxis) egg, (egg protein) neuralgia, paresthesia,

                  convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse
                  myelitis, Guillain-Barre Syndrome, dizziness, hypoesthesia, tremor, facial or cranial nerve
                  paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell’s Palsy),
                  exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis,
                  eosinophilic meningitis, vaccine associated encephalitis. This presents a clear medical danger to
                  name because these potentially dangerous medical concern would be exacerbated by introduction of
                  this vaccine to his/her body.

                  Supporting studies/evidence:
                  FLUMIST® QUADRIVALENT safely and effectively. See full prescribing information for FLUMIST®
                  https://www.fda.gov/vaccines-blood-biologics/lot-release/influenza-vaccine-2022-2023-season

                  Afluria Quadrivalent 2022-2023 (injection)
                  https://www.drugs.com/mtm/afluria-quadrivalent-2022-2023-injection.html
                  https://www.drugs.com/sfx/afluria-quadrivalent-side-effects.html

                      1. MMR Measles, Mumps, & Rubella
                        This vaccine is contraindicated for name, and certain individuals including those with: a history
                        of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic
                        reaction to *Neomycin; individuals who are immunodeficient or immunosuppressed due to disease or
                        medical therapy; an active febrile illness. Adverse concerns/ reactions are seizure or family
                        history of febrile seizures; immediate-type hypersensitivity reactions to eggs; and
                        thrombocytopenia. These medical concerns and reactions presents a clear medical danger to name due
                        to ingredients that would be exacerbated by introduction of these substance to his/her body.

                    Supporting studies/evidence:
                    MMR Vaccine – Priorix
                    https://www.chop.edu/news/news-views-what-should-i-know-about-new-mmr-vaccine-priorix

                    Priorix
                    https://ca.gsk.com/media/6254/priorix.pdf

                    *Neomycin
                    https://pubchem.ncbi.nlm.nih.gov/compound/neomycin

                    *Neomycin – Necrosis – The death of cells in an organ or tissue due to disease, injury or failure
                    of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic – The random
                    catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological
                    death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin –
                    section=Associated-Disorders-and-Diseases

                        1. Varicella (Chickenpox)
                          This vaccine is contraindicated for name because it contains the chemical compound, ALB – albumin
                          (human). Implicated in several diseases, including blood protein disease; hepatobiliary system
                          cancer (multiple); hyperthyroxinemia; middle cerebral artery infarction; and psoriasis. Biomarker
                          of several diseases, including carcinoma (multiple); heart disease (multiple); hematologic cancer
                          (multiple); liver disease (multiple); and lung disease (multiple). This presents a clear medical
                          danger to name because this toxin would be exacerbated by introduction of this substance to his/her
                          body. *Note: This gene has been reviewed for its involvement in coronavirus biology, and is
                          relevant for COVID- 19 prognosis.

                      Supporting Studies/evidence: ALB – albumin (human).
                      https://pubchem.ncbi.nlm.nih.gov/gene/213

                      Albumin (human)
                      https://www.drugs.com/mtm/albumin-human.html

                          1. HepA‡ Hepatitis A

                        This vaccine is contraindicated for name because it contains Aluminum. Aluminum negatively effects
                        the central nervous system and bones. Aluminum binds to dietary phosphorus and impairs
                        gastrointestinal absorption of aluminum. The decreased phosphate body burden results in
                        osteomalacia and rickets. Aluminum neurotoxicity is believed to involve different mechanisms.
                        Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier,
                        cholinergic activity, signal transduction pathways. It has been suggested that aluminum’s
                        interaction with estrogen receptors increases the expression of estrogen-related genes and thereby
                        contributes to the progression of breast cancer. This presents a clear medical danger to name
                        because this chemical compound is toxic, and would be exacerbated by introduction of this substance
                        to his/her body.

                        Supporting studies/evidence:
                        Havrix® (Hepatitis A Vaccine) injectable suspension, for intramuscular use
                        https://ca.gsk.com/media/6243/havrix.pdf

                        Al₂O₃ nanoparticles induce mitochondria-mediated cell death and upregulate the expression of
                        signaling genes in human mesenchymal stem cells
                        https://pubmed.ncbi.nlm.nih.gov/23132795/

                            1. Tdap: ≥7 yrs.
                              This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can
                              produce neurotoxicity, ototoxicity and/or nephrotoxicity. Severe allergic reaction (e.g.,
                              anaphylaxis) and progressive neurologic disorders, include – hypersensitivity and encephalopathy.
                              Neomycin is associated with delayed-onset irreversible deafness, renal failure and death due to
                              neuromuscular blockade (regardless of the status of renal function). Neomycin is used in veterinary
                              medicine as a bactericidal drug. GHS Hazard Statements: Harmful if swallowed – Warning Acute
                              toxicity, oral. May cause an allergic skin reaction May cause allergy or asthma symptoms or
                              breathing difficulties if inhaled. This presents a clear medical danger to name because this toxin
                              would be exacerbated by introduction of this substance to his/her body.

                          Supporting studies/evidence:
                          Neomycin
                          https://pubchem.ncbi.nlm.nih.gov/compound/neomycin

                          Neomycin
                          https://pubchem.ncbi.nlm.nih.gov/compound/neomycin

                          *Neomycin – Necrosis – The death of cells in an organ or tissue due to disease, injury or failure
                          of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic – The random
                          catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological
                          death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin –
                          section=Associated-Disorders-and-Diseases

                          13 (HPV) Human Papillomavirus
                          This vaccine is contraindicated for name because it contains serious health concerns for anyone
                          with allergic food (yeast), Adverse side effects associated HPV vaccine are: difficulty breathing,
                          wheezing (bronchospasm), hives, rash, vomiting, swollen glands (neck, armpit, or groin) joint pain
                          unusual tiredness, weakness, or confusion, chills, generally feeling unwell, leg pain, shortness of
                          breath, chest pain, aching muscles, muscle weakness, seizure, bleeding or bruising more easily than
                          normal, skin infection. *There are 85 Papillomavirus type strains (including non -human strains)
                          linked to this CDC Recommended Vaccine. This presents a clear medical danger to name because these
                          toxins would be exacerbated by introduction of this substance to his/her body.

                          Supporting studies/evidence:
                          Patient Information about GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
                          https://www.fda.gov/media/90070/download?attachment

                          *Patent Summary: Vaccine against HPV – 85 linked Papillomavirus strains
                          https://pubchem.ncbi.nlm.nih.gov/patent/EP-2318042-B1 – section=Linked-Proteins

                              1. Meningococcal (MenACWY-D: ≥9 mos, MenACWY-CRM: ≥2 mos, MenACWY-TT: ≥2years)

                            This vaccine is contraindicated for name because it contains the chemical compound, Diphtheria
                            Toxoid. As an ingredient, it is a carrier protein for polysaccharides and haptens to make them
                            immunogenic. The toxicity of Diphtheria Toxoid (CRM197) can cause damage to yeast cells and some
                            mammalian cell lines. Haptens are small molecules that elicit an immune response when attached to a
                            large carrier such as a protein; and they activate responses involving inflammatory cytokines.
                            *Examples of post market side adverse effects, associated with this vaccine include (not limited
                            too) – Blood and Lymphatic System Disorders, Lymphadenopathy, Immune System Disorders,
                            Hypersensitivity reactions such as anaphylaxis/anaphylactic reaction, wheezing, difficulty
                            breathing, upper airway swelling, urticaria, erythema, pruritus, and hypotension. This presents a
                            clear medical danger to name because these toxins would be exacerbated by introduction of this
                            substance to his/her body.

                            Supporting studies/evidence:
                            LABEL: MENACTRA-
                            Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen,
                            Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen,
                            Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and
                            Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen
                            injection, solution
                            https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d8781ff-9366-462c-8161-
                            6e958f44fcb4&audience=consumer – S11

                            Menactra®, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate
                            Vaccine
                            https://www.vaccineshoppe.com/assets/pdf/vsh/pi/menactrapi.pdf

                                1. Meningococcal serogroup B vaccination
                                  This vaccine is contraindicated for name because it contains an ingredient, Fc gamma receptor and
                                  transporter (FCGRT). This gene encodes a receptor that binds immunoglobulin G; and also binds
                                  immunoglobulin G to protect the antibody from degradation. Due to alternative splicing caused by
                                  interaction with various ingredients in the vaccine, multiple transcript variant can occur, and
                                  trigger autoimmune reactions. Disease associated with FCGRT is Myasthenia gravis.
                                  Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the
                                  communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia
                                  gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth,
                                  throat and limbs. The disease can strike anyone at any age. A myasthenia gravis crisis can involve
                                  difficulty in swallowing or breathing. The cause of myasthenia gravis is unknown and there is no
                                  cure. *The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the
                                  placenta. This presents a clear medical danger to name because these toxins would be exacerbated by
                                  introduction of this substance to his/her body.

                              Meningococcal group B vaccine Side Effects
                              https://www.drugs.com/sfx/meningococcal-group-b-vaccine-side-effects.html

                              Myasthenia Gravis
                              https://www.hopkinsmedicine.org/health/conditions-and-diseases/myasthenia-gravis

                                  1. (PPSV23) pneumococcal polysaccharides vaccine (PPSV), 23-valent
                                    This vaccine is contraindicated for name because it contains such harsh ingredients, and known
                                    toxins that trigger life threatening allergic reactions, and onset infections. A few examples of
                                    these life-threatening reactions are: Febrile convulsion, which are seizures or convulsions that
                                    occur in young children. Symptoms may include: loss of consciousness or passing out; uncontrollable
                                    shaking; eye rolling; rigid (stiff) limbs. Myocardial infarction (commonly called a heart attack)
                                    is an extremely dangerous condition that happens because of a lack of blood flow to your heart
                                    muscle; often resulting in death. Injection Cellulitis; Cellulitis is a potentially serious
                                    bacterial skin infection. The affected skin is swollen and inflamed and is typically painful and
                                    warm to the touch. Cellulitis is usually a superficial infection of the skin; if severe or if left
                                    untreated, it can spread into the lymph nodes and bloodstream and rapidly become life-threatening.
                                    These potential reactions presents a clear medical danger to name because these reactions would be
                                    exacerbated by introduction of this substance to his/her body.
                                    PNEUMOVAX 23 is indicated to help prevent pneumococcal disease caused by 23 serotypes
                                    https://www.merckvaccines.com/pneumovax23/

                                Pneumovax 23 Side Effects

                                Generic name: pneumococcal 23-polyvalent vaccine
                                https://www.drugs.com/sfx/pneumovax-23-side-effects.html

                                Febrile Seizures
                                https://www.ninds.nih.gov/health-information/disorders/febrile-seizures

                                Heart Attack (Myocardial Infarction)
                                https://my.clevelandclinic.org/health/diseases/16818-heart-attack-myocardial-infarction

                                Cellulitis
                                https://www.mayoclinic.org/diseases-conditions/cellulitis/symptoms-causes/syc-20370762

                                    1. (DEN4CYD: 9-16 yrs.)

                                    1. This vaccine is contraindicated for name because it has extreme adverse side effects, causing
                                      damaging health concerns. Some of them were: bleeding (tourniquet, petechiae or any bleeding) plus
                                      plasma leakage; Shock and hypotension with tachycardia, weak pulse and poor perfusion; Bleeding
                                      requiring blood transfusion; Encephalopathy i.e., unconsciousness or poor conscious state; poor
                                      conscious state or unconsciousness; Myocarditis, and pericarditis.

                                    1. Sanofi Pasteur licensed the first dengue vaccine (Dengvaxia®) in Mexico in 2015, and more than
                                      20 countries, thereafter, based on the safety and efficacy demonstrated in two phase III trials and
                                      a single season of disease surveillance. Unfortunately, the optimism that a dengue vaccine was
                                      finally available quickly became disappointment when a safety signal was observed in vaccine
                                      recipients who were dengue non-immune at the time of vaccine administration44,45. In the third year
                                      of the phase III clinical trial, the youngest, non-immune vaccine recipients experienced increased
                                      rates of hospitalized and severe dengue compared to their unvaccinated peers46. These potential
                                      reactions presents a clear medical danger to name because these toxins and/or reactions would be
                                      exacerbated by introduction of this substance to his/her body.

                                    1. Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16
                                      Years in Latin America
                                      https://classic.clinicaltrials.gov/ct2/show/NCT01374516

                                    1. Is new dengue vaccine efficacy data a relief or cause for concern?
                                      https://www.nature.com/articles/s41541-023-00658-2

                                  *Additional Information:

                                  HepA Hepatitis A Vaccines – Associated Disorders and Diseases Autism Spectrum Disorder
                                  Multiple Sclerosis, Chronic Progressive Bone Diseases, Metabolic Cardiovascular Diseases
                                  Brain Diseases Anemia
                                  Eye Diseases Memory Disorders Cognition Disorders Granuloma
                                  Heart Defects, Congenital Epilepsy, Tonic-Clonic Fragile X Syndrome Inflammation
                                  Lung Diseases Osteomalacia Lymphadenitis Nerve Degeneration Parkinson Disease

                                  Neoplasms Osteoporosis
                                  Bronchial Hyperreactivity
                                  Multiple Sclerosis, Relapsing-Remitting Neurodegenerative Diseases
                                  Chronic Kidney Disease-Mineral and Bone Disorder Chemical and Drug Induced Liver Injury
                                  Poisoning
                                  Diabetes Complications Dyslipidemias Respiratory Tract Diseases Neurotoxicity Syndromes Weight Loss
                                  Heavy Metal Poisoning

                                  Patent – Vaccine against HPV – GLAXOSMITHKLINE BIOLOG SA (BE)
                                  (HPV) Human Papillomavirus Stains – Presented as linked Proteins in Vaccine

                                  P50805 Major capsid protein L1 (Xipapillomavirus 1)

                                      • P50805 Major capsid protein L1 (Xipapillomavirus 1)

                                      • P08341 Major capsid protein L1 (Bos taurus papillomavirus 4)

                                      • P50807 Major capsid protein L1 (Bostaurus papillomavirus 6)

                                      • P03104 Major capsid protein L1 (Deltapapillomavirus 2)

                                      • P11326 Major capsidprotein L1 (Deltapapillomavirus 1)

                                      • P22163 Major capsid protein L1 (Alpha papillomavirus 12)

                                      • Q02273 Major capsid protein L1 (human papillomavirus 13)

                                      • Q02274 Major capsid protein L1 (Pygmy chimpanzee papillomavirus type 1)

                                      • P06456 Major capsid protein L1 (Chaffinch papillomavirus)

                                      • P06417 Major capsid protein L1 (Human papillomavirus type 8)

                                      • P04012 Major capsid protein L1 (human papillomavirus 11)

                                      • P03099 Major capsid protein L1 (Human papillomavirus type 1a)

                                      • P25486 Major capsid protein L1 (Human papillomavirus type 2a)

                                      • P17388 Major capsid protein L1 (human papillomavirus 31)

                                      • P06416 Major capsid protein L1 (human papillomavirus 33)

                                      • P27232 Major capsid protein L1 (human papillomavirus 35)

                                      • P24838 Major capsid protein L1 (human papillomavirus 39)

                                      • P27557 Major capsid protein L1 (Human papillomavirus type 41)

                                      • P27233 Major capsid protein L1 (human papillomavirus 42)

                                      • P50815 Major capsid protein L1 (human papillomavirus 43)

                                      • P50816 Major capsid protein L1 (human papillomavirus 44)

                                      • P36741 Major capsid protein L1 (human papillomavirus 45)

                                      • P22424 Major capsid protein L1 (human papillomavirus 47)

                                      • P26536 Major capsid protein L1 (human papillomavirus 51)

                                      • P36743 Major capsid protein L1 (human papillomavirus 56)

                                      • P26535 Major capsid protein L1 (human papillomavirus 58)

                                      • P26537 Major capsid protein L1 (Human papillomavirus type 5b)

                                      • P69899 Major capsid protein L1 (Human papillomavirus type 6b)

                                      • P27964 Major capsid protein L1 (Human papillomavirus type me180)

                                      • P36733 Major capsid protein L1 (human papillomavirus 12)

                                      • P36734 Major capsid protein L1 (human papillomavirus 14)

                                      • Q05137 Major capsid protein L1 (Human papillomavirus 15)

                                      • Q02514 Major capsid protein L1 (Human papillomavirus 17)

                                      • Q02050 Major capsid protein L1 (Human papillomavirus 19)

                                      • Q02051 Major capsid protein L1 (human papillomavirus 25)

                                      • Q02515 Major capsid protein L1 (human papillomavirus 30)

                                      • P36731 Major capsid protein L1 (Human papillomavirus 3)

                                      • P36740 Major capsid protein L1 (human papillomavirus 40)

                                      • P36742 Major capsid protein L1 (Human papillomavirus type 49)

                                      • Q07860 Major capsid protein L1 (Human papillomavirus 4)

                                      • Q05138 Major capsid protein L1 (human papillomavirus 52)

                                      • Q05136 Major capsid protein L1 (Human papillomavirus type 7)

                                      • Q02480 Major capsid protein L1 (Human papillomavirus 9)

                                      • Q07861 Major capsid protein L1 (Human papillomavirus type 63)

                                      • Q07874 Major capsid protein L1 (Human papillomavirus 65)

                                      • P50786 Major capsid protein L1 (human papillomavirus 20)

                                      • P50787 Major capsid protein L1 (human papillomavirus 21)

                                      • P03102 Major capsid protein L1 (Papillomavirus sylvilagi (STRAIN KANSAS))

                                      • P50791 Major capsid protein L1 (Human papillomavirus 28)

                                      • P50792 Major capsid protein L1 (Human papillomavirus 29)

                                      • P50820 Major capsid protein L1 (Human papillomavirus type 55)

                                      • P50822 Major capsid protein L1 (Human papillomavirus type 61)

                                      • P50824 Major capsid protein L1 (Human papillomavirus type 64)

                                      • Q80961 Major capsid protein L1 (human papillomavirus 66)

                                      • P50825 Major capsid protein L1 (human papillomavirus 67)

                                      • P50826 Major capsid protein L1 (human papillomavirus 69)

                                      • P69898 Major capsid protein L1 (Human papillomavirus type 6a)

                                      • P50788 Major capsid protein L1 (Human papillomavirus 22)

                                      • P50789 Major capsid protein L1 (Human papillomavirus 23)

                                      • P50790 Major capsid protein L1 (human papillomavirus 24)

                                      • P50812 Major capsid protein L1 (human papillomavirus 36)

                                      • P50813 Major capsid protein L1 (Human papillomavirus 37)

                                      • P50814 Major capsid protein L1 (Human papillomavirus 38)

                                      • P50793 Major capsid protein L1 (Human papillomavirus type 70)

                                      • P50806 Major capsid protein L1 (Epsilon papillomavirus 1)

                                      • P50817 Major capsid protein L1 (Human papillomavirus type 48)

                                      • P50818 Major capsid protein L1 (Human papillomavirus type 50)

                                      • P50821 Major capsid protein L1 (Human papillomavirus type 60)

                                      • P54669 Major capsid protein L1 (human papillomavirus 68)

                                      • Q9IR52 Major capsid protein L1 (human papillomavirus 82)

                                      • P36736 Major capsid protein L1 (human papillomavirus 27)

                                      • P22162 Major capsid protein L1 (human papillomavirus 57)

                                      • P36732 Major capsid protein L1 (Human papillomavirus type 10)

                                      • P03101 Major capsid protein L1 (Human papillomavirus type 16)

                                      • P06794 Major capsid protein L1 (Human papillomavirus type 18)

                                      • P36735 Major capsid protein L1 (Human papillomavirus type 26)

                                      • P36737 Major capsid protein L1 (Human papillomavirus type 32)

                                      • P36738 Major capsid protein L1 (Human papillomavirus type 34)

                                      • Q05113 Major capsid protein L1 (Human papillomavirus type 53)

                                      • P06917 Major capsid protein L1 (Human papillomavirus 5)

                                      • P50823 Major capsid protein L1 (human papillomavirus 62)

                                      • P03103 Major capsid protein L1 (Deltapapillomavirus 4)

                                      • Q89828 Major capsid protein L1 (Canine oral papillomavirus (strain Y62))

                                      • P50819 Major capsid protein L1 (Human papillomavirus type 54)

                                      • P06458 Major capsid protein L1 (Bos taurus papillomavirus 2)

                                    More To Explore

                                    Articles

                                    The Hidden Truth – CDC Recommended Childhood Vaccines

                                    Supporting studies/evidence:Safety Datasheet: ENGERIX-B PRESERVATIVE FREE = * HEPATITIS B SURFACE ANTIGENhttps://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.pdf Vaccine – Hepatitis B (Recombinant DNA) Vaccine (Absorbed)Composition/information on ingredients: Disodium Hydrogen Phosphatehttps://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.pdf

                                    Articles

                                    Follow the Money: Blood Money in U.S Healthcare

                                    Monograph #1: Slide PresentationFinancial Incentives:the Use of “CoveredCountermeasures” Paper Summary Brief-Financial Incentives: The Use of “Covered Countermeasures”